Martin Wiselka

8.4k total citations
61 papers, 1.1k citations indexed

About

Martin Wiselka is a scholar working on Epidemiology, Infectious Diseases and Surgery. According to data from OpenAlex, Martin Wiselka has authored 61 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Epidemiology, 25 papers in Infectious Diseases and 10 papers in Surgery. Recurrent topics in Martin Wiselka's work include Infectious Diseases and Tuberculosis (8 papers), Tuberculosis Research and Epidemiology (7 papers) and Pneumocystis jirovecii pneumonia detection and treatment (6 papers). Martin Wiselka is often cited by papers focused on Infectious Diseases and Tuberculosis (8 papers), Tuberculosis Research and Epidemiology (7 papers) and Pneumocystis jirovecii pneumonia detection and treatment (6 papers). Martin Wiselka collaborates with scholars based in United Kingdom, Australia and Belgium. Martin Wiselka's co-authors include Karl G. Nicholson, Iain Stephenson, Frank C. Odds, Jan Schmid, David R. Soll, K. G. Nicholson, Nagini Sarvananthan, Tristan Clark, D.A. BURNS and C. Barr Taylor and has published in prestigious journals such as The Lancet, Journal of Clinical Microbiology and Journal of Hepatology.

In The Last Decade

Martin Wiselka

58 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martin Wiselka United Kingdom 20 529 507 163 121 87 61 1.1k
Hugo López‐Gatell Mexico 18 847 1.6× 604 1.2× 213 1.3× 73 0.6× 72 0.8× 47 1.4k
A. Boibieux France 20 593 1.1× 571 1.1× 161 1.0× 195 1.6× 84 1.0× 95 1.1k
Abdul Rahman Bizri Lebanon 17 309 0.6× 360 0.7× 148 0.9× 104 0.9× 49 0.6× 66 989
Raúl Ortíz de Lejarazu Spain 24 1.0k 1.9× 438 0.9× 118 0.7× 68 0.6× 111 1.3× 119 1.8k
Josip Begovać Croatia 21 649 1.2× 679 1.3× 163 1.0× 103 0.9× 244 2.8× 111 1.3k
Sunil Bhatt India 13 490 0.9× 398 0.8× 296 1.8× 157 1.3× 51 0.6× 48 1.0k
Séverine Ansart France 17 378 0.7× 307 0.6× 227 1.4× 85 0.7× 36 0.4× 49 895
Svein Arne Nordbø Norway 24 908 1.7× 745 1.5× 145 0.9× 204 1.7× 45 0.5× 83 1.7k
Mary Bavaro United States 20 635 1.2× 522 1.0× 125 0.8× 190 1.6× 190 2.2× 35 1.3k
Teresa Hernández‐Sampelayo Spain 19 529 1.0× 374 0.7× 99 0.6× 82 0.7× 75 0.9× 82 978

Countries citing papers authored by Martin Wiselka

Since Specialization
Citations

This map shows the geographic impact of Martin Wiselka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Wiselka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Wiselka more than expected).

Fields of papers citing papers by Martin Wiselka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Wiselka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Wiselka. The network helps show where Martin Wiselka may publish in the future.

Co-authorship network of co-authors of Martin Wiselka

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Wiselka. A scholar is included among the top collaborators of Martin Wiselka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Wiselka. Martin Wiselka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gogoi, Mayuri, Christopher Martin, Paul Bird, et al.. (2024). Risk of vaccine preventable diseases in UK migrants: A serosurvey and concordance analysis. Journal of Migration and Health. 9. 100217–100217. 3 indexed citations
2.
White, Helena, Hajra Okhai, Amandip Sahota, et al.. (2021). Latent tuberculosis screening and treatment in HIV: highly acceptable in a prospective cohort study. ERJ Open Research. 8(2). 442–2021. 3 indexed citations
3.
Molina, Jean‐Michel, Birgit Grund, Fred M. Gordin, et al.. (2018). Which HIV-infected adults with high CD4 T-cell counts benefit most from immediate initiation of antiretroviral therapy? A post-hoc subgroup analysis of the START trial. The Lancet HIV. 5(4). e172–e180. 23 indexed citations
4.
Richardson, Matthew, Martin Wiselka, Robert C. Free, et al.. (2018). A nested case–control study of predictors for tuberculosis recurrence in a large UK Centre. BMC Infectious Diseases. 18(1). 94–94. 12 indexed citations
5.
Pareek, Manish, John Innes, Saranya Sridhar, et al.. (2015). Vitamin D deficiency and TB disease phenotype. Thorax. 70(12). 1171–1180. 28 indexed citations
6.
White, Helena, et al.. (2014). Antenatal hepatitis B in a large teaching NHS Trust – Implications for future care. Journal of Infection. 70(1). 72–77. 3 indexed citations
7.
Cartwright, Katharine, Tristan Clark, Abid Hussain, et al.. (2011). Eumycetoma of the Hand Caused by Leptosphaeria tompkinsii and Refractory to Medical Therapy with Voriconazole. Mycopathologia. 172(4). 311–315. 4 indexed citations
8.
Miller, Robert F., Maryam Shahmanesh, M D Talbot, et al.. (2006). Progressive symptoms and signs following institution of highly active antiretroviral therapy and subsequent antituberculosis therapy: immune reconstitution syndrome or infection?. Sexually Transmitted Infections. 82(2). 111–116. 7 indexed citations
9.
Marei, Ayman, Amir M. Ghaemmaghami, Philip S. Renshaw, et al.. (2005). Superior T cell activation by ESAT-6 as compared with the ESAT-6–CFP-10 complex. International Immunology. 17(11). 1439–1446. 28 indexed citations
10.
Stephenson, Iain, et al.. (2003). Dengue fever in febrile returning travellers to a UK regional infectious diseases unit. Travel Medicine and Infectious Disease. 1(2). 89–93. 19 indexed citations
11.
Wiselka, Martin, et al.. (1999). Cytomegalovirus viraemia has poor predictive value for the development of cytomegalovirus disease in patients with advanced HIV-infection. Journal of Infection. 39(3). 187–192. 8 indexed citations
12.
Sarvananthan, Nagini, et al.. (1998). Intraocular Tuberculosis Without Detectable Systemic Infection. Archives of Ophthalmology. 116(10). 1386–1386. 44 indexed citations
13.
Wiselka, Martin, Robert C. Read, & R. Finch. (1996). Response to oral and intravenous azithromycin in a patient with toxoplasma encephalitis and AIDS. Journal of Infection. 33(3). 227–229. 12 indexed citations
14.
Nicholson, Karl G., et al.. (1994). Varicella pneumonitis: a role for extra-corporeal membrane oxygenation?. Journal of Infection. 28(1). 65–67. 6 indexed citations
15.
Wiselka, Martin, et al.. (1993). Schistosomiasis in Leicester. Journal of Infection. 26(2). 177–179. 7 indexed citations
16.
Wiselka, Martin. (1992). A clinical overview of opportunistic infections in patients with AIDS. PubMed. 2. 1–22. 2 indexed citations
17.
Brown, Lawrence A., Martin Wiselka, A. C. Campbell, et al.. (1991). High‐grade T‐cell lymphoma following treatment with cyclosporin A. Histopathology. 19(3). 225–230. 3 indexed citations
18.
Wiselka, Martin, James B. Kent, & Karl G. Nicholson. (1990). Malaria in Leicester 1983–1988: A review of 114 cases. Journal of Infection. 20(2). 103–110. 9 indexed citations
19.
Wiselka, Martin, et al.. (1989). Malaria prophylaxis in travellers from Britain. Journal of Infection. 18(3). 209–212. 20 indexed citations
20.
Nicholson, Karl G., Martin Wiselka, & Amanda L. May. (1987). Influenza vaccination of the elderly: perceptions and policies of general practitioners and outcome of the 1985–86 immunization programme in Trent, UK. Vaccine. 5(4). 302–306. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026